The Dosimetric Comparation of Malignant Glioma Between the 3D-CRT and the IMRT

李莉,马秀梅,曹鸿斌,戴立言,侯艳丽,吴旭东,白永瑞,叶明
DOI: https://doi.org/10.3969/j.issn.1007-3639.2008.12.006
2008-01-01
Abstract:Background and purpose:Malignant gliomas are not very sensitive to radiation .One has to escalate the dose in order to prolong survival. But due to restraint of the normal tissues,total dose can no be raised to a higher level when using 3D-CRT. We compared the difference between the 3D-CRT and the IMRT of patients with malignant glioma by 3DTPS. Methods:From July. 2006 to Oct. 2007,we separately designed 11 malignant glioma patients’ plan by IMRT and 3D-CRT. We compared the difference between the two kinds of plan in V90,V95,Dmin,Dmax,Dmean and CI of the target volume,and the Dmax and Dmean of normal tissues as well as ID of nontarget normal tissue. Results:The dose coverage rate of PTV1,PTV2,dose of left optic nerve and ID of low dose region(0.5~25 Gy) about the non-target normal tissue in the IMRT plan was comparable to the 3D-CRT with no statistical difference in dosimetry comparison. However,there was obvious difference in PGTV,CI(95%1.39 vs 2.74 P0.001) ,Dmean of PGTV,Dmax and Dmin of PTV1 and PTV2,ID of total non-target normal tissue and some normal tissues between IMRT and 3D-CRT. Conclusion:Both IMRT and 3D-CRT plan have good coverage of the primary tumor. IMRT can give higher dose to the tumor and spare the normal tissue from high dose irradiation. It is a good selection for malignant glioma patients.
What problem does this paper attempt to address?